The Alternative Heart: Impact of Alternative Splicing in Heart Disease

被引:70
|
作者
Lara-Pezzi, Enrique [1 ]
Gomez-Salinero, Jesus [1 ]
Gatto, Alberto [1 ]
Garcia-Pavia, Pablo [2 ]
机构
[1] Ctr Nacl Invest Cardiovasc, Cardiovasc Dev & Repair Dept, Madrid 28029, Spain
[2] Hosp Univ Puerta Hierro Majadahonda, Dept Cardiol, Madrid, Spain
关键词
Alternative splicing; Molecular cardiology; Sarcomere; Cell signalling; Ion channels; Antisense oligonucleotides; CARDIAC TROPONIN-T; PRE-MESSENGER-RNA; UNFOLDED PROTEIN RESPONSE; BINDING-PROTEIN; DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; MYOTONIC-DYSTROPHY; PASSIVE STIFFNESS; ALPHA-TROPOMYOSIN; CHLORIDE CHANNEL;
D O I
10.1007/s12265-013-9482-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alternative splicing is the main driver of protein diversity and allows the production of different proteins from each gene in the genome. Changes in exon exclusion, intron retention or the use of alternative splice sites can alter protein structure, localisation, regulation and function. In the heart, alternative splicing of sarcomeric genes, ion channels and cell signalling proteins can lead to cardiomyopathies, arrhythmias and other pathologies. Also, a number of inherited conditions and heart-related diseases develop as a result of mutations affecting splicing. Here, we review the impact that changes in alternative splicing have on individual genes and on whole biological processes associated with heart disease. We also discuss promising therapeutic tools based on the manipulation of alternative splicing.
引用
收藏
页码:945 / 955
页数:11
相关论文
共 50 条
  • [31] MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development
    Kalsotra, Auinash
    Wang, Kun
    Li, Pei-Feng
    Cooper, Thomas A.
    GENES & DEVELOPMENT, 2010, 24 (07) : 653 - 658
  • [32] Genome-wide analysis of alternative splicing during human heart development
    Wang, He
    Chen, Yanmei
    Li, Xinzhong
    Chen, Guojun
    Zhong, Lintao
    Chen, Gangbing
    Liao, Yulin
    Liao, Wangjun
    Bin, Jianping
    SCIENTIFIC REPORTS, 2016, 6
  • [33] Protein Kinase C regulates alternative splicing transitions during heart development
    Verma, Sunil K.
    Deshmukh, Vaibhav
    Kuyumcu-Martinez, Muge N.
    CIRCULATION RESEARCH, 2013, 113 (04)
  • [34] Genome-wide analysis of alternative splicing during human heart development
    He Wang
    Yanmei Chen
    Xinzhong Li
    Guojun Chen
    Lintao Zhong
    Gangbing Chen
    Yulin Liao
    Wangjun Liao
    Jianping Bin
    Scientific Reports, 6
  • [35] A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart
    Kalsotra, Auinash
    Xiao, Xinshu
    Ward, Amanda J.
    Castle, John C.
    Johnson, Jason M.
    Burge, Christopher B.
    Cooper, Thomas A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (51) : 20333 - 20338
  • [36] Exon Organization and Novel Alternative Splicing of Ank3 in Mouse Heart
    Yamankurt, Gokay
    Wu, Henry C.
    McCarthy, Michael
    Cunha, Shane R.
    PLOS ONE, 2015, 10 (05):
  • [37] ALTERNATIVE SPLICING OF CYSTIC-FIBROSIS TRANSMEMBRANE REGULATOR CHLORIDE CHANNELS IN HEART
    TSUNG, SS
    HART, P
    LEVESQUE, PC
    HUME, JR
    HOROWITZ, B
    CLINICAL RESEARCH, 1993, 41 (01): : A2 - A2
  • [38] Heart Rate and Cardiovascular Disease: An Alternative to Beta Blockers
    Liang, Michael
    Puri, Aniket
    Devlin, Gerard
    CARDIOLOGY RESEARCH AND PRACTICE, 2009, 2009
  • [39] What is the role of alternative biomarkers for coronary heart disease?
    Garg, Abhimanyu
    CLINICAL ENDOCRINOLOGY, 2011, 75 (03) : 289 - 293
  • [40] IMPACT OF ALTERNATIVE CORONARY HEART-DISEASE RISK FACTOR MODIFICATIONS ON LIFE EXPECTANCY
    TSEVAT, J
    WEINSTEIN, MC
    WILLIAMS, LW
    TOSTESON, ANA
    LEE, TH
    GOLDMAN, L
    CLINICAL RESEARCH, 1989, 37 (02): : A784 - A784